Curis reported $806K in Interest Income for its fiscal quarter ending in September of 2023.





Interest Income Change Date
AstraZeneca USD 73M 62M Mar/2026
Bayer EUR 130M 38M Sep/2025
CSL USD 18M 1000K Dec/2024
Curis USD 806K 9K Sep/2023
Eli Lilly USD 65M 25M Sep/2025
Exelixis USD 17.43M 1.5M Dec/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 33.69M 2.93M Mar/2026
Merck USD 69M 27M Dec/2025
Pfizer USD 166M 166M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Verastem USD 831K 1.04M Sep/2024